• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Bio-Works Technologies

3.54 SEK+0.28 %15.7. klo 18.25
Less than 1K followers

BIOWKS

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.28 %
-3.01 %
+4.73 %
+32.09 %
+35.11 %
+108.24 %
-62.94 %
-72.41 %
-58.80 %

Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.

Read more
Market cap
355.47M SEK
Turnover
12.96K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
21.8.
2026

Interim report Q2'26

6.11.
2026

Interim report Q3'26

19.2.
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release15.07.2026 klo 12.30

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 7 of 11

Bio-Works Technologies
Regulatory press release06.07.2026 klo 09.00

Bio-Works Technologies AB: Bio-Works Receives Order for 8,9 MSEK from Returning Customer

Bio-Works Technologies
Regulatory press release01.07.2026 klo 09.00

Today is the first day of the seventh exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release01.07.2026 klo 08.00

Bio-Works Technologies AB - Business Update second quarter 2026

Bio-Works Technologies
Regulatory press release04.06.2026 klo 11.20

Bio-Works Technologies AB: Resolutions passed at Bio-Works Technologies' annual general meeting 2026

Bio-Works Technologies
Regulatory press release13.05.2026 klo 09.00

Bio-Works Technologies AB: Bio-Works reports first quarter 2026

Bio-Works Technologies
Regulatory press release29.04.2026 klo 16.17

Bio-Works Technologies AB: Bio-Works receives order for WorkBeads 40S from contract manufacturer in Europe

Bio-Works Technologies
Regulatory press release17.04.2026 klo 15.00

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 6 of 11

Bio-Works Technologies
Regulatory press release10.04.2026 klo 09.00

Bio-Works Technologies AB: Proposed New Board Members in Bio-Works

Bio-Works Technologies
Regulatory press release01.04.2026 klo 09.00

Today is the first day of the sixth exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies
Regulatory press release01.04.2026 klo 09.00

Bio-Works Technologies AB - Business Update first quarter 2026

Bio-Works Technologies
Press release13.03.2026 klo 14.29

Redeye: Bio-Works (Intervju): Verksamhetsuppdatering

Bio-Works Technologies
Regulatory press release06.03.2026 klo 15.00

Bio-Works Technologies AB publishes Business Update ahead of next value creation phase

Bio-Works Technologies
Regulatory press release20.02.2026 klo 09.00

Bio-Works Technologies AB: Bio-Works publishes Year-end report Q4 2025

Bio-Works Technologies
Regulatory press release17.02.2026 klo 15.29

Bio-Works Technologies AB: Bio-Works Receives Order from Returning Customer

Bio-Works Technologies
Regulatory press release19.01.2026 klo 13.30

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 5 of 11

Bio-Works Technologies
Regulatory press release02.01.2026 klo 09.00

Today is the first day of the fifth exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies
Regulatory press release02.01.2026 klo 08.00

Bio-Works Technologies AB: Business Update

Bio-Works Technologies
Regulatory press release29.12.2025 klo 09.00

Bio-Works Technologies AB: Bio-Works Receives Two WorkBeads 100S and 100Q Orders Worth SEK 4 Million

Bio-Works Technologies
Regulatory press release15.12.2025 klo 17.00

Bio-Works Technologies AB Annual General Meeting to be held on Thursday 4 of June 2026

Bio-Works Technologies